Don E. Smith

发表

Anthony D. Kelleher, Victor Appay, Laura Papagno, 2002, The Journal of Immunology.

Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-Tat Ribozyme in a Multi-Center, Randomized, Placebo-Controlled, Phase II Gene Therapy Trial for the Human Immunodeficiency Virus

C. von Kalle, T. Merigan, M. Winters, 2009, Nature Medicine.

Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial

J. Gatell, H. Teppler, F. Raffi, 2019, Antiviral therapy.

Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

Dominic Michael Dwyer, S. Emery, J. Amin, 2014, PloS one.

Estimating antiretroviral treatment coverage rates and viral suppression rates for homosexual men in Australia.

David P. Wilson, K. Petoumenos, N. L. De La Mata, 2015, Sexual health.

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

D. Cooper, M. Law, J. Amin, 2002, JAMA.

Centralized Assessment of Dual-Energy X-ray Absorptiometry (DEXA) in Multicenter Studies of HIV-Associated Lipodystrophy

D. Cooper, M. Law, Allison Martin, 2003, HIV clinical trials.

Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study.

S. Scholten, B. Wynne, M. Ait-Khaled, 2021, Journal of acquired immune deficiency syndromes.

Progressive Activation of CD127+132− Recent Thymic Emigrants into Terminally Differentiated CD127−132+ T-Cells in HIV-1 Infection

D. Cooper, A. Kelleher, J. Zaunders, 2012, PloS one.

Atazanavir Plasma Concentrations Vary Significantly Between Patients and Correlate with Increased Serum Bilirubin Concentrations

Don E. Smith, J. Ray, S. Jeganathan, 2006, HIV clinical trials.

Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive.

M. Law, K. Petoumenos, J. Hoy, 2017, Sexual health.

Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity.

J. Gold, Don E. Smith, 2007, Sexual health.

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

D. Cooper, S. Emery, C. Ringland, 2004, AIDS.

Non-AIDS complexity amongst patients living with HIV in Sydney: risk factors and health outcomes

J. Post, Don E. Smith, Mithilesh Dronavalli, 2018, AIDS Research and Therapy.

Progression of Lipodystrophy (LD) with Continued Thymidine Analogue Usage: Long-Term Follow-Up from a Randomized Clinical Trial (The PIILR Study)

S. Mallal, D. Cooper, M. Law, 2004, HIV clinical trials.

Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.

D. Cooper, M. Law, Allison Martin, 2002, AIDS.

Translation of clinical trial data to changes in clinical practice: rapid transition from tenofovir disoproxil fumarate to tenofovir alafenamide-based therapies in a Sydney HIV clinic

Don E. Smith, Merrion Tom, Bruce H Bowden, 2018, International journal of STD & AIDS.

Multi-Centre Evaluation of the Determine HIV Combo Assay when Used for Point of Care Testing in a High Risk Clinic-Based Population

R. Guy, A. McNulty, Don E. Smith, 2014, PloS one.

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

Christof von Kalle, Roger Garsia, Robert Finlayson, 2009, Nature medicine.

Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection.

B. Autran, M. Battegay, L. Perrin, 2005, The Journal of infectious diseases.

Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus‐like particle, combined with zidovudine, in asymptomatic subjects

D. Cooper, A. Kelleher, G. Patou, 1998, AIDS.

Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study.

Stephen T. Wright, D. Cooper, M. Law, 2016, Sexual health.

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

S. Mallal, D. Cooper, M. Law, 2001, AIDS.

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection

D. Cooper, A. Kelleher, J. Zaunders, 2000, AIDS.

Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy

D. Cooper, J. Zaunders, M. Bloch, 2000, AIDS.

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy

D. Cooper, J. Zaunders, M. Bloch, 2002, AIDS.

Treatment and Prophylaxis of Pneumocystis carinii Pneumonia in AIDS Patients

B. Gazzard, Don E. Smith, 1991, Drugs.

Correlation between HIV-1 RNA load in blood and seminal plasma depending on antiretroviral treatment status, regimen and penetration of semen by antiretroviral drugs.

M. Batterham, Don E. Smith, J. Ray, 2008, Current HIV research.

Relationship between HIV-RNA load in blood and semen in antiretroviral-naïve and experienced men and effect of asymptomatic sexually transmissible infections.

Don E. Smith, D. J. Chan, M. Batterham, 2008, Current HIV research.

Efficient Diagnosis of Pneumocystis Carinii Pneumonia

Don E. Smith, 1994, International journal of STD & AIDS.

HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults

S. Dawson, M. Dawson, K. Petoumenos, 2021, Nature Medicine.

Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before-after study.

R. Guy, A. McNulty, G. Prestage, 2019, Sexual Health.

Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.

D. Cooper, A. Kelleher, J. Zaunders, 2006, The Journal of infectious diseases.

Treating primary HIV infection--is your HAART in it?

Don E. Smith, D. J. Chan, 2004, Sexual health.

Correction: Multi-Centre Evaluation of the Determine HIV Combo Assay when Used for Point of Care Testing in a High Risk Clinic-Based Population

R. Guy, A. McNulty, Don E. Smith, 2014, PLoS ONE.

High Viral Fitness during Acute HIV-1 Infection

A. Kelleher, M. Law, D. McPhee, 2010, PloS one.

S. Dawson, M. Dawson, K. Petoumenos, 2020 .

Rates of combination antiretroviral treatment change in Australia, 1997–2000

C. Moore, S. Mallal, D. Cooper, 2002 .

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

J. D. de Wit, L. Cysique, M. Giles, 2017, AIDS.

Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection1 2

Alan S. Perelson, Ruy M. Ribeiro, John Zaunders, 2002, The Journal of Immunology.

Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.

J. Corbeil, D. Richman, S. Little, 2003, The Journal of infectious diseases.

Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study.

David Bruce Lewis, R. Guy, P. Read, 2021, The lancet. HIV.

Barriers to HIV testing and characteristics associated with never testing among gay and bisexual men attending sexual health clinics in Sydney

R. Guy, A. McNulty, Don E. Smith, 2015, Journal of the International AIDS Society.

Rapid HIV Testing Is Highly Acceptable and Preferred among High-Risk Gay And Bisexual Men after Implementation in Sydney Sexual Health Clinics

R. Guy, A. McNulty, Don E. Smith, 2015, PloS one.

Case report and evaluation of the frequency of the prozone phenomenon in syphilis serology - an infrequent but important laboratory phenomenon.

P. Robertson, L. R. Whybin, J. Post, 2012, Sexual health.

What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales' public sexual health services compared with other services?

A. McNulty, E. Jackson, Don E. Smith, 2013, Sexual health.

Trends in practice: attitudes and challenges in the diagnosis, treatment and management of HIV infection in Australia

Don E. Smith, I. Woolley, D. Russell, 2020, Internal medicine journal (Print).

POST-EXPOSURE PROPHYLAXIS FOR NON-OCCUPATIONAL EXPOSURE TO HIV: EXPERIENCE IN NSW ONE YEAR AFTER THE INTRODUCTION OF THE GUIDELINES

P. Correll, A. Grulich, Don E. Smith, 2000 .

A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations

C. Morrison, P. Vanhems, A. Kamali, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Empiric antimicrobial treatment for asymptomatic sexual contacts of sexually transmitted infection in the era of antimicrobial resistance: time to rethink?

Don E. Smith, D. J. Chan, Elizabeth Pearce, 2018, International journal of STD & AIDS.

Correlates of unprotected anal intercourse in HIV positive men attending an HIV/AIDS clinic in Sydney.

M. Batterham, Don E. Smith, S. Jeganathan, 2008, Current HIV research.

Loss to follow-up in the Australian HIV Observational Database

M. Law, K. Petoumenos, M. Giles, 2014, Antiviral therapy.

Reducing Viral Load Measurements to Once a Year in Patients on Stable, Virologically Suppressive Cart Regimen: Findings from the Australian HIV Observational Database

Stephen T. Wright, M. Law, K. Petoumenos, 2014, Journal of AIDS & clinical research.

Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: results from the Australian HIV Observational Database Temporary Residents Access Study

Stephen T. Wright, M. Law, K. Petoumenos, 2015, Journal of the International AIDS Society.

Utility of rapid plasmin reagin titres in assessing treatment response and re-infection for infectious syphilis.

J. Post, W. Rawlinson, Don E. Smith, 2020, Sexual health.

Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment

C. Cohen, S. Esser, Don E. Smith, 2016, AIDS care.

Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

E. Rosenberg, B. Walker, J. Kaldor, 2005, Blood.

Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries

M. Battegay, D. Cooper, P. Phanuphak, 2002, Expert opinion on investigational drugs.

Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir.

S. Lewin, D. Cooper, S. Wesselingh, 2004, The Journal of infectious diseases.

by simple outpatient assessments . pneumonia in HIV antibody positive patients Diagnosis of Pneumocystis carinii

A. Forbes, B. Gazzard, Don E. Smith, 2022 .

Chronic HIV Infection Circles Differ After Treatment of Acute and Dynamics of T Cells and TCR Excision

Ajantha, A. Perelson, S. Lewin, 2002 .

Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral Therapy

Stephen T. Wright, K. Petoumenos, M. Boyd, 2014, Journal of acquired immune deficiency syndromes.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

B. Gazzard, J. Montaner, R. Weber, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?

E. Rosenberg, B. Walker, J. Kaldor, 2004, AIDS.

The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection: Final Results From a Randomized Clinical Trial (Pulse)

J. Kaldor, D. Cooper, A. Kelleher, 2006, Journal of acquired immune deficiency syndromes.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

Anne M Johnson, C. Morrison, P. Vanhems, 2017, The Journal of antimicrobial chemotherapy.

Overlapping HIV prevention strategies; case report of pre-exposure and postexposure prophylaxes used for a single risk event between two men

Don E. Smith, J. Gardiner, D. Fagan, 2015, Sexually Transmitted Infections.

Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide–Based Regimens

C. Katlama, R. Batterham, S. Scholten, 2023, Open forum infectious diseases.

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion

C. Morrison, P. Vanhems, A. Kamali, 2017, HIV medicine.

Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.

B. Gazzard, D. Smith, Don E. Smith, 1991, AIDS.

Eflornithine versus cotrimoxazole in the treatment of Pneumocystis carinii pneumonia in AIDS patients

B. Gazzard, D. Smith, B. Gazzard, 1992, AIDS.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

S. Lewin, D. Cooper, A. Kelleher, 2008, Journal of acquired immune deficiency syndromes.

Clinical experience with nevirapine combined with tenofovir plus emtricitabine or lamivudine-containing regimens in HIV-infected subjects

Don E. Smith, D. J. Chan, H. Maruszak, 2011, International journal of STD & AIDS.

Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion.

J. Kahn, F. Hecht, D. Cooper, 2003, AIDS research and human retroviruses.

Multi-centre field evaluation of the performance of the Trinity Biotech Uni-Gold HIV 1/2 rapid test as a first-line screening assay for gay and bisexual men compared with 4th generation laboratory immunoassays.

D. E. Smith, R. Guy, P. Read, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.